Large volume re-irradiation with bevacizumab is a feasible salvage option for patients with refractory high-grade glioma

por Back, Michael, Gzell, Cecelia E., Kastelan, Marina, Guo, Linxin, Wheeler, Helen R.
Publicado no Neurooncol Pract (2015)

Correlation of MicroRNA 132 Up-regulation with an Unfavorable Clinical Outcome in Patients with Primary Glioblastoma Multiforme Treated with Radiotherapy Plus Concomitant and Adjuv...

por Parker, Nicole R, Correia, Nelson, Crossley, Brendan, Buckland, Michael E, Howell, Viive M, Wheeler, Helen R
Publicado em 2013

Sub-acute Toxicity in Non-cancerous Tissue and Immune-Related Adverse Events of a Novel Combination Therapy for Cancer

por McKelvey, Kelly J., Hudson, Amanda L., Prasanna Kumar, Ramyashree, Eade, Thomas, Clarke, Stephen J., Wheeler, Helen R., Diakos, Connie I., Howell, Viive M.
Publicado no Front Oncol (2020)

Glioblastoma Recurrence Correlates With Increased APE1 and Polarization Toward an Immuno-Suppressive Microenvironment

por Hudson, Amanda L., Parker, Nicole R., Khong, Peter, Parkinson, Jonathon F., Dwight, Trisha, Ikin, Rowan J., Zhu, Ying, Chen, Jason, Wheeler, Helen R., Howell, Viive M.
Publicado no Front Oncol (2018)

Are In Vitro Human Blood–Brain–Tumor-Barriers Suitable Replacements for In Vivo Models of Brain Permeability for Novel Therapeutics?

por Prashanth, Archana, Donaghy, Heather, Stoner, Shihani P., Hudson, Amanda L., Wheeler, Helen R., Diakos, Connie I., Howell, Viive M., Grau, Georges E., McKelvey, Kelly J.
Publicado no Cancers (Basel) (2021)

Intratumoral heterogeneity identified at the epigenetic, genetic and transcriptional level in glioblastoma

por Parker, Nicole R., Hudson, Amanda L., Khong, Peter, Parkinson, Jonathon F., Dwight, Trisha, Ikin, Rowan J., Zhu, Ying, Cheng, Zhangkai Jason, Vafaee, Fatemeh, Chen, Jason, Wheeler, Helen R., Howell, Viive M.
Publicado no Sci Rep (2016)

Temporal and spatial modulation of the tumor and systemic immune response in the murine Gl261 glioma model

por McKelvey, Kelly J., Hudson, Amanda L., Prasanna Kumar, Ramyashree, Wilmott, James S., Attrill, Grace H., Long, Georgina V., Scolyer, Richard A., Clarke, Stephen J., Wheeler, Helen R., Diakos, Connie I., Howell, Viive M.
Publicado no PLoS One (2020)

A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma

por Brandes, Alba A., Carpentier, Antoine F., Kesari, Santosh, Sepulveda-Sanchez, Juan M., Wheeler, Helen R., Chinot, Olivier, Cher, Lawrence, Steinbach, Joachim P., Capper, David, Specenier, Pol, Rodon, Jordi, Cleverly, Ann, Smith, Claire, Gueorguieva, Ivelina, Miles, Colin, Guba, Susan C., Desaiah, Durisala, Lahn, Michael M., Wick, Wolfgang
Publicado no Neuro Oncol (2016)

Biomarker and Histopathology Evaluation of Patients with Recurrent Glioblastoma Treated with Galunisertib, Lomustine, or the Combination of Galunisertib and Lomustine

por Capper, David, von Deimling, Andreas, Brandes, Alba A., Carpentier, Antoine F., Kesari, Santosh, Sepulveda-Sanchez, Juan M., Wheeler, Helen R., Chinot, Olivier, Cher, Lawrence, Steinbach, Joachim P., Specenier, Pol, Rodon, Jordi, Cleverly, Ann, Smith, Claire, Gueorguieva, Ivelina, Miles, Colin, Guba, Susan C., Desaiah, Durisala, Estrem, Shawn T., Lahn, Michael M., Wick, Wolfgang
Publicado no Int J Mol Sci (2017)